Subgroups
Protocols (2)
Outcomes & scoring
biomarker-neutrophil-engraftment-time-days-measured1 evidence row
| Protocol | Effect | Confidence | N |
|---|---|---|---|
| therapy-post-transplant-cyclophosphamide-cyclosporin-gvhd-prophylaxis-generic | 0 | 85 | 67 |
biomarker-platelet-recovery-time-days-measured1 evidence row
| Protocol | Effect | Confidence | N |
|---|---|---|---|
| therapy-post-transplant-cyclophosphamide-cyclosporin-gvhd-prophylaxis-generic | -10 | 85 | 67 |
| Protocol | Effect | Confidence | N |
|---|---|---|---|
| therapy-post-transplant-cyclophosphamide-cyclosporin-gvhd-prophylaxis-generic | +70 | 85 | 67 |
immune-gvhd-acute-incidence-measured1 evidence row
immune-gvhd-chronic-incidence-cohort-measured1 evidence row
| Protocol | Effect | Confidence | N |
|---|---|---|---|
| therapy-post-transplant-cyclophosphamide-cyclosporin-gvhd-prophylaxis-generic | 0 | 85 | 67 |
survival-gvhd-relapse-free-proportion-cohort-measured1 evidence row
| Protocol | Effect | Confidence | N |
|---|---|---|---|
| therapy-post-transplant-cyclophosphamide-cyclosporin-gvhd-prophylaxis-generic | +75 | 85 | 67 |
survival-overall-at-2-years-proportion-cohort-measured1 evidence row
| Protocol | Effect | Confidence | N |
|---|---|---|---|
| therapy-post-transplant-cyclophosphamide-cyclosporin-gvhd-prophylaxis-generic | +40 | 85 | 67 |
Path: therapy › post